GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (SZSE:002399) » Definitions » Other Stockholders Equity

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Other Stockholders Equity : ¥7,055 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Other Stockholders Equity?

Shenzhen Hepalink Pharmaceutical Group Co's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,055 Mil.

Shenzhen Hepalink Pharmaceutical Group Co's quarterly Other Stockholders Equity increased from Sep. 2023 (¥6,626 Mil) to Dec. 2023 (¥7,062 Mil) but then declined from Dec. 2023 (¥7,062 Mil) to Mar. 2024 (¥7,055 Mil).

Shenzhen Hepalink Pharmaceutical Group Co's annual Other Stockholders Equity increased from Dec. 2021 (¥6,299 Mil) to Dec. 2022 (¥6,532 Mil) and increased from Dec. 2022 (¥6,532 Mil) to Dec. 2023 (¥7,062 Mil).


Shenzhen Hepalink Pharmaceutical Group Co Other Stockholders Equity Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Other Stockholders Equity Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -997.41 -1,101.69 6,299.32 6,531.74 7,062.13

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,525.99 -891.10 6,626.49 7,062.13 7,055.44

Shenzhen Hepalink Pharmaceutical Group Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Shenzhen Hepalink Pharmaceutical Group Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.
Executives
Zhang Ping Director
Li Li Director
Kong Yun Executives
Li Tan Directors, executives

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Headlines

No Headlines